Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar, J Bruneau… - Liver …, 2019 - Wiley Online Library
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
E Day, M Hellard, C Treloar, J Bruneau… - … : Official Journal of the …, 2018 - europepmc.org
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
E Day, M Hellard, C Treloar, J Bruneau… - Liver …, 2019 - search.ebscohost.com
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
[HTML][HTML] Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar, J Bruneau… - … : official journal of the …, 2019 - ncbi.nlm.nih.gov
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar… - … : official journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
[PDF][PDF] Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar, J Bruneau, NK Martin… - Liver Int, 2019 - researchgate.net
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar… - Liver …, 2019 - research-information.bris.ac.uk
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
… Network on Hepatitis in Substance Users - Liver …, 2019 - einstein.elsevierpure.com
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar, J Bruneau… - Liver …, 2019 - portal.findresearcher.sdu.dk
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar, J Bruneau… - Liver …, 2019 - discovery.dundee.ac.uk
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …
with an estimated prevalence of greater than 40%, representing an estimated 5.6 million …